Barclays Sees Upside In Teleflex, Raises Price Target

Loading...
Loading...
Barclays' Matthew Taylor reiterated
Telefex IncorporatedTFX
at Overweight, raising the price target to $183.00. The price objective change came after the analyst met with management last week.

Related Link: Teleflex Sees FY2016 Guidance $7.10 To $7.25

"The TFX business appears healthy," stated the analyst. Taylor listed five highlights behind the price target increase:

  • Utilization has trended positively in the United States
  • The company expected to be active on the M&A front
  • There are several upside drivers to margins
  • GPO wins hit a new record in 1Q
  • The company's "Percuvance launch is on track for 3Q in the US"

At the time of writing, Telefex traded at $173.24, up 0.01 percent.

Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorLong IdeasHealth CarePrice TargetReiterationAnalyst RatingsTechTrading IdeasGeneralBarcalysMatthew Taylor
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...